Cargando…
Systemic White Blood Cell Count as a Biomarker for Chronic Obstructive Pulmonary Disease: Utility and Limitations
Autor principal: | Kim, Tae-Hyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526961/ https://www.ncbi.nlm.nih.gov/pubmed/28747967 http://dx.doi.org/10.4046/trd.2017.80.3.313 |
Ejemplares similares
-
Systemic White Blood Cell Count as a Biomarker Associated with Severity of Chronic Obstructive Lung Disease
por: Koo, Hyeon-Kyoung, et al.
Publicado: (2017) -
Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: A Biomarker of Inhaled Corticosteroid Effects
por: Singh, Dave
Publicado: (2020) -
Transcriptome-based Signatures: The Future Biomarkers in Obstructive Pulmonary Diseases Such as Asthma and Chronic Obstructive Pulmonary Disease?
por: van den Berge, Maarten, et al.
Publicado: (2021) -
Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease
por: Sivapalan, Pradeesh, et al.
Publicado: (2021) -
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
por: Singh, Dave, et al.
Publicado: (2020)